5 articles
With seven UK patients implanted under the GB-PRIME study and a total of twenty worldwide, Neuralink's R1 surgical robot has moved to Cleveland Clinic Abu Dhabi for the next cohort under the UAE-PRIME trial.
NeuCyber Neurotech's rotating CEO concedes a significant technology gap with Musk's outfit, even as China pours state funding into catching up and expanding human trials to 50 patients.
In just nine months China has issued a national BCI blueprint, overtaken the United States in BCI patent filings, funnelled hundreds of millions into startups, and has just granted the world's first commercial implant approval.
With 12+ patients implanted and mass production planned for 2026, Neuralink's clinical reality is more complicated and more human than the headlines suggest.
FDA grants approval for Neuralink to enroll significantly more participants in its brain-computer interface clinical trials, marking a major step toward commercialization.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.